You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
安科生物(300009.SZ):擬作為基石投資者參與維昇藥業香港首次公開發行
格隆匯 02-11 22:05

格隆匯2月11日丨安科生物(300009.SZ)公佈,公司於2025年2月10日召開第八屆董事會第十七次會議審議通過《關於全資子公司對外投資的議案》,同意公司擬使用自有資金不超過3100萬美元(包括經紀佣金及徵費等相關手續費)通過全資子公司安科生物(香港)有限公司(以下簡稱“安科生物(香港)”),作為基石投資者參與認購VISEN Pharmaceuticals(中文名稱“維昇藥業”,以下簡稱“維昇藥業”或“標的公司”)擬在香港聯合交易所(以下簡稱“香港聯交所”)發行的首次公開發行股份,並簽署《基石投資協議》,具體持股比例將根據發行市值確定。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account